The Deltatrac Metabolic Monitor (DTC), one of the most popular indirect calorimetry systems for measuring resting metabolic rate (RMR) in human subjects, is no longer being manufactured. This study compared five different gas analysis systems to the DTC. Resting metabolic rate was measured by the DTC and at least one other instrument at three study sites for a total of 38 participants. The five indirect calorimetry systems included: MedGraphics CPX Ultima, MedGem, Vmax Encore 29 System, TrueOne 2400, and Korr ReeVue. Validity was assessed using paired t-tests to compare means while reliability was assessed by using both paired t-tests and root mean square calculations with F tests for significance. Within-subject comparisons for validity of RMR revealed a significant difference between the DTC and Ultima. Bland-Altman plot analysis showed significant bias with increasing RMR values for the Korr and MedGem. Respiratory exchange ratio (RER) analysis showed a significant difference between the DTC and the Ultima and a trend for a difference with the Vmax (p = 0.09). Reliability assessment for RMR revealed that all instruments had a significantly larger coefficient of variation (CV) (ranging from 4.8% to 10.9%) for RMR compared to the 3.0 % CV for the DTC. Reliability assessment for RER data showed none of the instrument CV's were significantly larger than the DTC CV. The results were quite disappointing, with none of the instruments equaling the within person reliability of the DTC. The TrueOne and Vmax were the most valid instruments in comparison with the DTC for both RMR and RER assessment. Further testing is needed to identify an instrument with the reliability and validity of the DTC.Correspondence and request for reprints: Dr. Dale Schoeller,
Body composition assessment has been used to evaluate clinical interventions in research trials, and has the potential to improve patient care in the clinical setting. Body cell mass (BCM) is an important indicator of nutrition status; however, its measurement in the clinic has been limited. BCM can be estimated by the measurement of intracellular water (ICW). The assessment of extracellular water (ECW) is also important because many clinical populations undergo alterations in fluid distribution, particularly individuals with wasting, those receiving dialysis, and obese individuals. Bioimpedance spectroscopy (BIS) is a unique bioimpedance approach that differs in underlying basis from the more readily recognized single-frequency bioelectrical impedance analysis (SF-BIA) in that it does not require the use of statistically derived, population-specific prediction equations. It has the potential advantage of not only measuring total body water (TBW), as does SF-BIA, but also offering the unique capacity to differentiate between ECW and ICW and, thus, to provide an estimate of BCM. This literature review was conducted to compare available BIS devices to multiple dilution for measuring fluid compartments or BCM in a number of populations. Variable results regarding the ability of BIS to measure absolute volumes, as well as the observation of wide limits of variation, make BIS problematic for individual assessment in the clinic, particularly in populations with abnormal fluid distribution or body geometry. BIS has been found to be more accurate for measuring changes in fluid volumes or BCM, particularly in post-surgical and human immunodeficiency virus (HIV)-infected individuals. It is certainly possible that population-specific adjustments may improve the accuracy of BIS for assessing individuals in the clinical setting; however, additional research and development is needed before the method can be accepted for routine clinical use.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.